english.prescrire.org > About Prescrire > "Non merci"
"Non merci"

"Non merci": Prescrire = no conflicts of interest

Prescrire's pioneering "Non merci..." Charter guarantees that Prescrire's editors and managers are free from any conflicts of interest.

In order to deliver the best possible care, healthcare professionals need to base their work and their decisions on reliable and independent information.

"Non merci..."
Prescrire's "Non merci..." Charter specifies all the influences to which healthcare professionals and patients are exposed. Signatories pledge to promote quality care, and to act to distance themselves from these influences. The Charter is signed every year by all members of Association Mieux Prescrire.
To read the "Non merci..." Charter online, click here.

> Download the "Non merci..." Charter (pdf, 178 Ko)

No conflicts of interest for the managers and all the members of Editorial Staff
Every year, Prescrire's managers, the members of the Editorial Staff and the directors of Association Mieux Prescrire sign a personal statement of absence of conflicts of interest.

> Declaration of Absence of Conflicts of Interest (pdf, 115 Ko)

The hallmarks of independence are not just petty details
Association Mieux Prescrire has taken precautions to protect itself against conflicts of interest of any kind:

  • AMP does not sell, lease or otherwise transfer subscribers' addresses a to any other person or organisation;
  • AMP does not accept subscriptions paid for by pharmaceutical companies on behalf of healthcare professionals;
  • AMP does not accept bulk sales of subscriptions to trade unions or professional groups;
  • Prescrire staff do not accept any gifts from pharmaceutical companies. They do not accept any invitations, and do not participate in any sponsored trips;
  • Prescrire is self-supporting and meets all its own needs, including research materials;
  • Prescrire bases its work on clinical trial data, and not on promotional materials;
  • Prescrire carefully checks information provided by pharmaceutical companies, by medical experts and by other sources that are potentially subject to influence.

©Prescrire November 2016